PO.CH03.01 · 化学
The cryo-EM structure of ADGRL4 provides functional insights into its mechanism of activation
作者与单位
摘要 Abstract
Background
ADGRL4 (also known as ELTD1) is an orphan adhesion G protein-coupled receptor (aGPCR) upregulated in multiple aggressive malignancies where it promotes angiogenesis, proliferation and epithelial-mesenchymal transition. Its molecular activation mechanism however was previously unknown. We demonstrated that ADGRL4 couples weakly to the heterotrimeric G protein G q and determined the first active-state cryo-EM structure of ADGRL4. We then combined the structural data with systematic mutagenesis and G protein recruitment assays to define the molecular determinants of tethered agonist (TA) mediated activation.
Methods
A split NanoLuc-proximity assay using engineered ADGRL4 and mini-G protein constructs was used to quantitate Gq coupling. We purified the active-state ADGRL4-mini-G q -betagamma complex and determined its structure by cryo-EM. Guided by the structure, we performed alanine-scanning mutagenesis on TA residues contacting the orthosteric binding pocket and selected residues within the receptor core, assessing effects on G q recruitment in HEK293T cells.
Results
Cryo-EM analysis yielded the first high-resolution structure of active-state ADGRL4 to 3.1 Å resolution. The TA region forms a short alpha-helix that occupies the orthosteric site and promotes outward displacement of transmembrane helix 6 (TM6). Alanine substitution of seven out of eight TA residues that interact with the orthosteric pocket significant impaired G q recruitment. Mutation of six residues (H408A, F409A, I411A, L412A, M413A, S414A) reduced coupling by >50%; M413A abolished coupling completely ( p <0.0001) and F409A reduced coupling by 88% ( p <0.0001). Previous aGPCR structures have proposed three conserved core activation motifs: the upper quaternary core motif (UQC), the hydrophobic P/F/W/LφφG motif, and the H(N)L(M)Y motif. Structure-guided mutagenesis of corresponding positions in ADGRL4 showed that mutation of any UQC residue to alanine (F505A, M508A, W631A) abolished G q recruitment. In the P/F/W/LφφG motif, L627A and G628 eliminated activity, whilst F625A and L626A caused partial impairment. In the H(N)L(M)Y motif, L515A and Y516A abolished coupling, whilst H514A produced partial impairment. Together, these findings clarify ADGRL4's activation mechanism: exposure of the TA permits engagement with the orthosteric pocket, which in turns facilitates TM6 displacement and formation of a cytoplasmic cleft for G q engagement, with all activation motifs functioning as essential structural elements of this process.
Conclusions
These findings define how ADGRL4's TA and conserved 7TM activation motifs cooperatively stabilise its active conformation and engage G q . These findings establish a structural framework for developing ADGRL4-selective antagonists (nanobodies, synthetic binders or small molecules) with potential therapeutic utility in ADGRL4-associated malignancies.
利益披露 Disclosure
D. M. Favara, None..
Q. Chen, None..
A. Gusach, None.
A. Diamante,
Nxera Pharma UK Limited Employment.
J. C. Patel,
Nxera Pharma UK Limited Employment.
P. C. Edwards, None.
C. G. Tate,
Nxera Pharma UK Limited Stock.